Easterseals NH & VT plans to close Farnum’s inpatient substance use disorder treatment program at 140 Queen City Ave. in Manchester, effective July 20, the nonprofit announced Wednesday.
While no new inpatient admissions will be accepted after that date, current patients will be allowed to complete their treatment. Outpatient services will continue at Farnum’s Lake Avenue location, Easterseals said in a letter signed by president and CEO Maureen Beauregard and board chair Bryan Bouchard.
Maureen Beauregard, president and CEO of Easterseals NH and VT, speaks about her journey during Leadership Unscripted at the Rex Theatre in Manchester on June 6. The nonprofit plans to close its inpatient substance use disorder treatment program in Manchester.(Photo by Jodie Andruskevich)
The closure follows a two-year review of Easterseals NH’s services and an unsuccessful search for another provider to take over inpatient operations. Easterseals leaders cited major shifts in the SUD treatment landscape — including competition from larger, national providers with better insurance access — as factors that have strained Farnum’s financial viability.
The difficult decision was made only after exploring all alternatives, the organization said in the statement, noting the priority now is to ensure continuity of care and support for affected staff.
Community members with questions are encouraged to contact farnumquestions@eastersealsnh.org.
Two for-profit methadone clinics in Derry and Salem are under investigation as part of a statewide initiative looking into unnecessary barriers patients might face when seeking treatment for opioid addiction.
Bedford Ambulatory Surgical Center (BASC) has added a powerful new tool to its orthopedic suite: endoscopic spine surgery.
Lebanon company’s breast cancer locator won the nh tech alliance’s product of the year in 2021
Novo Nordisk has lowered its full-year 2025 sales and operating profit forecasts due to weaker-than-expected growth in its key obesity and diabetes drugs, the Danish drugmaker announced Tuesday. Novo Nordisk employs more than 400 people at its West Lebanon, NH, location.
Cairn Surgical Inc., which is developing technology designed to make breast cancer surgery more precise, has received ISO 13485:2016 certification for the quality management system associated with the its Breast Cancer Locator System, the Lebanon company announced Thursday.
Two local doctors are working with an independent provider to increase contact time
HCA’s acquisition of CMC reshapes maternity and primary care in Manchester, raising questions about access, consolidation, and community impact.
NH has the nation’s lowest health insurance costs—but new state and federal laws could drive premiums up for many residents in coming years.
Another national settlement with opioid manufacturers is poised to infuse Granite State drug prevention, treatment and recovery programs with a new wave of funding, the NH Attorney General’s Office announced Thursday, July 10.
